Impact of recent FDA ruling on testosterone replacement therapy (TRT)

被引:11
|
作者
Metzger, Sarita O. [1 ]
Burnett, Arthur L. [1 ]
机构
[1] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA
关键词
ANDROGEN DEFICIENCY SYNDROMES; CLINICAL-PRACTICE GUIDELINE; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; ONSET HYPOGONADISM; ELDERLY-MEN; OLDER MEN; ASSOCIATION; MORTALITY;
D O I
10.21037/tau.2016.09.08
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:921 / 926
页数:6
相关论文
共 50 条
  • [21] Testosterone replacement therapy
    Velazquez, E
    Arata, GB
    ARCHIVES OF ANDROLOGY, 1998, 41 (02): : 79 - 90
  • [22] Testosterone replacement therapy
    Barbonetti, Arcangelo
    D'Andrea, Settimio
    Francavilla, Sandro
    ANDROLOGY, 2020, 8 (06) : 1551 - 1566
  • [23] Testosterone replacement therapy
    Jones, T. H.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (10) : 547 - 553
  • [24] Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS)
    Desai, Ankit
    Yassin, Musaab
    Cayetano, Axel
    Tharakan, Tharu
    Jayasena, Channa N.
    Minhas, Suks
    THERAPEUTIC ADVANCES IN UROLOGY, 2022, 14
  • [25] Evidence-based Medicine Update on Testosterone Replacement Therapy (TRT) in Male Hypogonadism: Focus on New Formulations
    Giagulli, V. A.
    Triggiani, V.
    Corona, G.
    Carbone, D.
    Licchelli, B.
    Tafaro, E.
    Resta, F.
    Sabba, C.
    Maggi, M.
    Guastamacchia, E.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (15) : 1500 - 1511
  • [26] Clinical outcomes of testosterone replacement therapy (TRT) in Japanese patients with late-onset hypogonadism (LOH) syndrome
    Kuratsukuri, K.
    Minami, A.
    Matsuda, T.
    Naganuma, J.
    Uchida, J.
    Nakatani, T.
    BJU INTERNATIONAL, 2019, 123 : 40 - 41
  • [27] THE IMPACT OF TESTOSTERONE REPLACEMENT THERAPY ON LOWER URINARY TRACT SYMPTOMS
    Pastuszak, A.
    Badhiwala, N.
    Lipshultz, L.
    Khera, M.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 : 268 - 268
  • [28] Assessment of the Association Between the Use of Testosterone Replacement Therapy (TRT) and the Increased Risk of Venous Thrombotic Events (VTE) Among TRT Treated and Untreated Hypogonadal Men
    Li, Hu
    Ostrowski, Nancy L.
    Benoit, Karin
    Wang, Wei
    Motsko, Stephen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 41 - 42
  • [29] Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer
    Lenfant, Louis
    Leon, Priscilla
    Cancel-Tassin, Geraldine
    Audouin, Marie
    Staerman, Frederic
    Roupret, Morgan
    Cussenot, Olivier
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (08) : 661 - 670
  • [30] National use of testosterone replacement therapy: annual trends and response to recent evidence
    Lucas, Eleanor
    Daubresse, Matthew
    Singh, Sonal
    Stafford, Randall
    Alexander, G. Caleb
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 113 - 114